Filing Details

Accession Number:
0001437749-16-031717
Form Type:
4
Zero Holdings:
No
Publication Time:
2016-05-12 18:40:57
Reporting Period:
2016-05-10
Filing Date:
2016-05-12
Accepted Time:
2016-05-12 18:40:57
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1427925 Acelrx Pharmaceuticals Inc ACRX () 4
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1190429 G Mark Edwards C/O Acelrx Pharmaceuticals, Inc.
351 Galveston Drive
Redwood City CA 94063
Yes No No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2016-05-10 5,000 $3.25 105,000 No 4 P Direct
Common Stock Acquisiton 2016-05-11 5,000 $3.15 110,000 No 4 P Direct
Common Stock Acquisiton 2016-05-12 5,000 $3.05 115,000 No 4 P Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 P Direct
No 4 P Direct
No 4 P Direct